137 related articles for article (PubMed ID: 36063707)
1. Incidence of antipsychotic use among community dwellers with and without Parkinson's disease.
Lilja S; Tolppanen AM; Koponen M; Hartikainen S; Tiihonen M
Parkinsonism Relat Disord; 2022 Oct; 103():69-72. PubMed ID: 36063707
[TBL] [Abstract][Full Text] [Related]
2. Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease.
Pirttilä A; Tiihonen M; Paakinaho A; Hartikainen S; Tolppanen AM
J Am Med Dir Assoc; 2023 Sep; 24(9):1290-1296.e4. PubMed ID: 37220871
[TBL] [Abstract][Full Text] [Related]
3. Incidence of antidepressant use among community dwellers with and without Parkinson's disease - a nationwide cohort study.
Hentilä E; Tiihonen M; Taipale H; Hartikainen S; Tolppanen AM
BMC Geriatr; 2021 Mar; 21(1):202. PubMed ID: 33757451
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study.
Koponen M; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Ahonen R; Hartikainen S
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1706-13. PubMed ID: 26233607
[TBL] [Abstract][Full Text] [Related]
5. Risk of pneumonia associated with atypical antipsychotic use in nursing home residents with Parkinson's disease.
Chekani F; Holmes HM; Johnson ML; Chen H; Sherer JT; Aparasu RR
J Psychiatr Res; 2019 Oct; 117():116-121. PubMed ID: 31377483
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
[TBL] [Abstract][Full Text] [Related]
7. Incidence of cataract surgeries in relation to diagnosis of Parkinson's disease.
Lampela P; Tolppanen AM; Kaarniranta K; Hokkinen K; Hartikainen S
Arch Gerontol Geriatr; 2023 Jan; 104():104842. PubMed ID: 36272228
[TBL] [Abstract][Full Text] [Related]
8. Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson's Disease and Comorbid Depression.
Chekani F; Holmes HM; Johnson ML; Chen H; Sherer JT; Aparasu RR
Drug Healthc Patient Saf; 2020; 12():23-30. PubMed ID: 32099480
[TBL] [Abstract][Full Text] [Related]
9. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.
Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Am Geriatr Soc; 2020 Mar; 68(3):595-602. PubMed ID: 31912482
[TBL] [Abstract][Full Text] [Related]
10. Cost of antipsychotic polypharmacy in the treatment of schizophrenia.
Zhu B; Ascher-Svanum H; Faries DE; Correll CU; Kane JM
BMC Psychiatry; 2008 Apr; 8():19. PubMed ID: 18394168
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
Friedman JH; Factor SA
Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic use in older adults with Parkinson's disease.
Marras C; Kopp A; Qiu F; Lang AE; Sykora K; Shulman KI; Rochon PA
Mov Disord; 2007 Feb; 22(3):319-23. PubMed ID: 17149718
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.
van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
Eur J Clin Pharmacol; 2002 May; 58(2):157-61. PubMed ID: 12012150
[TBL] [Abstract][Full Text] [Related]
14. Low continuation of antipsychotic therapy in Parkinson disease - intolerance, ineffectiveness, or inertia?
Pham Nguyen TP; Abraham DS; Thibault D; Weintraub D; Willis AW
BMC Neurol; 2021 Jun; 21(1):240. PubMed ID: 34167473
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease.
Koponen M; Rajamaki B; Lavikainen P; Bell JS; Taipale H; Tanskanen A; Hartikainen S; Tolppanen AM
J Am Med Dir Assoc; 2022 Jun; 23(6):1059-1065.e4. PubMed ID: 34717887
[TBL] [Abstract][Full Text] [Related]
16. Incidence of muscle relaxant use in relation to diagnosis of Parkinson's disease.
Paakinaho A; Karttunen N; Koponen M; Taipale H; Tolppanen AM; Hartikainen S; Tiihonen M
Int J Clin Pharm; 2020 Apr; 42(2):336-340. PubMed ID: 32144610
[TBL] [Abstract][Full Text] [Related]
17. Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease.
Wang MT; Lian PW; Yeh CB; Yen CH; Ma KH; Chan AL
Mov Disord; 2011 Aug; 26(9):1663-9. PubMed ID: 21630354
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics in Parkinson-sensitive populations.
Friedman JH; Fernandez HH
J Geriatr Psychiatry Neurol; 2002; 15(3):156-70. PubMed ID: 12230086
[TBL] [Abstract][Full Text] [Related]
19. Risk of Mortality Associated With Atypical Antipsychotic use: A National Cohort Study of Older Adults With Depression and Parkinson's Disease.
Chekani F; Holmes HM; Johnson ML; Chen H; Sherer JT; Aparasu RR
Am J Geriatr Psychiatry; 2020 Oct; 28(10):1079-1088. PubMed ID: 32147383
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Cardiovascular Drugs and Oral Anticoagulant Use among Persons with and without Parkinson's Disease.
Babar BA; Kettunen R; Tiihonen M; Hartikainen S; Tolppanen AM
Cardiology; 2024; 149(2):127-136. PubMed ID: 38071963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
